These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Indications and results of endemic goiter drug therapy with synthetic thyroid hormones]. Horster FA; Wildmeister W Acta Endocrinol Suppl (Copenh); 1973 Oct; 179():89-90. PubMed ID: 4523787 [No Abstract] [Full Text] [Related]
6. [Conservative treatment of euthyroid and recurrent goiter using a thyroid hormone drug]. Klug W Zentralbl Chir; 1970 Feb; 95(8):249-53. PubMed ID: 5512987 [No Abstract] [Full Text] [Related]
7. [Results of thyroid hormone therapy in bland struma]. Meng W; Meng S; Hampel R; Ventz M; Zeisler A Z Gesamte Inn Med; 1982 Aug; 37(16):540-2. PubMed ID: 6815911 [TBL] [Abstract][Full Text] [Related]
9. [Euthyroid struma with a thyroid nodule. Is the combination of L-thyroxine and iodine effective here?]. Füessl HS; Stiefelhagen P MMW Fortschr Med; 2014 Apr; 156(8):17. PubMed ID: 24851428 [No Abstract] [Full Text] [Related]
10. [Effectiveness of goiter treatment with L-thyroxine in patients over 40]. Wollmann B; Meller J; Hüfner M; Becker W Nuklearmedizin; 1998 Jan; 37(1):41-4. PubMed ID: 9467169 [TBL] [Abstract][Full Text] [Related]
11. [Non-toxic nodular goiter: treatment and follow-up]. Mereu P; Scala M; Schenone F; Schenone G; Comandini D; Gipponi M; Margarino G Acta Otorhinolaryngol Ital; 1995 Aug; 15(4):301-4. PubMed ID: 8928662 [TBL] [Abstract][Full Text] [Related]
12. Dyshormonogenetic goitre. Vittal S; Chandrasekaran M; Kumar KB; Sucharitha V; Jeevaratinam R J R Coll Surg Edinb; 1993 Aug; 38(4):205-7. PubMed ID: 7693928 [TBL] [Abstract][Full Text] [Related]
13. [Percutaneous ethanol injection in combination with euthyrox suppressive therapy in the treatment of benign nodular goiter]. Meskhi IA; Sikharulidze EN; Natmeladze KV Georgian Med News; 2007 May; (146):11-3. PubMed ID: 17595451 [TBL] [Abstract][Full Text] [Related]
14. [The postoperative course of atoxic struma with and without thyroxine to reduce the risk of relapse]. Geerdsen JP Nord Med; 1986; 101(11):304-5. PubMed ID: 3786128 [No Abstract] [Full Text] [Related]
17. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease. De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104 [TBL] [Abstract][Full Text] [Related]
18. The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapy. Fast S; Bonnema SJ; Hegedüs L Clin Endocrinol (Oxf); 2008 Oct; 69(4):653-8. PubMed ID: 18363890 [TBL] [Abstract][Full Text] [Related]
19. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases. Bossowski A; Czarnocka B; Bardadin K; Urban M; Niedziela M; Dadan J Horm Res; 2008; 70(3):155-64. PubMed ID: 18663316 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of endemic goiter with L-thyroxine]. Schnorrenberg G Med Klin; 1970 Jun; 65(24):1167-9. PubMed ID: 5517343 [No Abstract] [Full Text] [Related] [Next] [New Search]